Taiwan Advance Bio-Pharmaceutical Inc. (TPEX:4186)
8.88
0.00 (0.00%)
Aug 4, 2026, 1:14 PM CST
TPEX:4186 Market Cap
TPEX:4186 has a market cap or net worth of 799.2 million as of August 4, 2026. Its market cap has decreased by -13.79% in one year.
Market Cap
799.20M
Enterprise Value
922.58M
Revenue
364.79M
Ranking
n/a
PE Ratio
28.65
Stock Price
8.88
ChartMarket Cap Chart
Since November 27, 2012, TPEX:4186's market cap has decreased from 4.10B to 799.20M, a decrease of -80.50%. That is a compound annual growth rate of -11.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 802.80M | -20.00% |
| Dec 31, 2025 | 1.00B | -29.21% |
| Dec 31, 2024 | 1.42B | -4.55% |
| Dec 29, 2023 | 1.49B | -6.78% |
| Dec 30, 2022 | 1.59B | -4.84% |
| Dec 30, 2021 | 1.67B | -26.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GeneReach Biotechnology | 994.21M |
| Lukas Biomedical | 979.86M |
| Holy Stone Healthcare | 912.34M |
| TCI GENE | 899.59M |
| Meribank Biotech | 872.42M |
| BioLASCO Taiwan | 799.09M |
| NatureWise Biotech & Medicals | 767.16M |
| Neith | 710.20M |